Aveanna Healthcare Hldgs Raises FY2026 Sales Guidance from $2.540B-$2.560B to $2.560B-$2.580B vs $2.559B Est
Aveanna Healthcare Holdings Inc
Aveanna Healthcare Holdings Inc AVAH | 0.00 |
Full Year 2026 Guidance
The following is our guidance reflecting our increased expectations for revenue and Adjusted EBITDA for the full fiscal year 2026 (year ending January 2, 2027):
- Revenue of between $2.56 and $2.58 billion, updated from between $2.54 and $2.56 billion
Consistent with prior practice, we are not providing guidance on net income at this time due to the volatility of certain required inputs that are not available without unreasonable efforts, including future fair value adjustments associated with our interest rate swaps and caps.
- Adjusted EBITDA of between $328 and $332 million, updated from between $318 and $322 million
